In summary, our work aims at improving the understanding of the role of Ikaros/SHIP1 regulation and AKT isoforms in ALL, which could form the basis of a new targeted intervention of ALL in the future. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.